Results 171 to 180 of about 4,728,853 (203)
Some of the next articles are maybe not open access.
American Journal of Respiratory Cell and Molecular Biology, 1999
Abstract The distribution and regulation of leukemia inhibitory factor (LIF) and its receptor (LIFR) in human lung tissue is unknown. We recently found that LIF was immunolocalized to several cell types in human airways, and that exogenous LIF modulated neural and contractile responses of explanted airways.
D A, Knight +5 more
openaire +2 more sources
Abstract The distribution and regulation of leukemia inhibitory factor (LIF) and its receptor (LIFR) in human lung tissue is unknown. We recently found that LIF was immunolocalized to several cell types in human airways, and that exogenous LIF modulated neural and contractile responses of explanted airways.
D A, Knight +5 more
openaire +2 more sources
Leukemia inhibitory factor, LIF receptor, and gp130 in the mouse uterus during early pregnancy
Leukemia inhibitory factor (LIF) has been shown to play an important role in the implantation of mouse blastocysts. The present study was designed to investigate the changes of LIF protein, LIF receptor, and gp130 in the mouse uterus during the early ...
Zeng-Ming Yang +2 more
exaly +1 more source
Modulation of PDGF mediated osteoblast chemotaxis by leukemia inhibitory factor LIF
Journal of Cellular Physiology, 1996Cell migration is a key event in tissue repair and remodeling. PDGF, a growth factor for multiple target cells, has been shown to be a potent chemoattractant for a variety of mesenchymal cells. However, it is likely that PDGF-mediated cell migration will be influenced by other cytokines that can be produced during physiological and pathological ...
S, Chandrasekhar, A K, Harvey
openaire +2 more sources
Clearance and fate of leukemia‐inhibitory factor (LIF) after injection into mice
Journal of Cellular Physiology, 1991AbstractLeukemia‐inhibitory factor (LIF) elicits effects on a broad range of cell types, including cells of the monocytic and megakaryocytic series, embryonal stem cells, hepatocytes, adipocytes, and osteoblasts. Native and recombinant LIF, injected intravenously into adult mice, had an initial half‐life of 6‐8 min and a more prolonged second clearance
D J, Hilton +3 more
openaire +2 more sources
Evaluation of Leukemia Inhibitory Factor (LIF) in a Rat Model of Postoperative Pain
The Journal of Pain, 2011Postoperative pain remains a significant problem despite optimal treatment with current pharmaceutical agents. In an effort to provide better postoperative pain control, there is a need to understand the factors that contribute to the development of pain after surgery.
Christina M, Spofford +4 more
openaire +2 more sources
Molecular Genetics of Leukemia Inhibitory Factor (LIF) and its Receptor
Growth Factors, 1992(1992). Molecular Genetics of Leukemia Inhibitory Factor (LIF) and its Receptor. Growth Factors: Vol. 7, No. 3, pp. 175-179.
openaire +2 more sources
Leukemia inhibitory factor (LIF) and its biological activity.
Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina, 2005Leukemia inhibitory factor (LIF) is a pleiotropic glycoprotein belonging to the IL-6 family of cytokines. It shows a wide range of biologic activities that include the growth promotion and cell differentiation of different types of target cells, influence on bone metabolism, cachexia, neural development, embryogenesis and inflammation.
Chodorowska, Grażyna. +2 more
openaire +1 more source
The gene for human leukemia inhibitory factor (LIF) maps to 22q12.
Leukemia, 1989The gene for human leukemia inhibitory factor (LIF) has been mapped by Southern analysis of a series of mouse/human somatic cell hybrids and by in situ hybridization to the chromosomes of two normal males and some individuals with chromosomal rearrangements.
G R, Sutherland +5 more
openaire +1 more source
Leukemia inhibitory factor (LIF); LIF receptor
Science-Business eXchange, 2014openaire +1 more source

